Ptc Therapeutics (PTCT) Net Margin (2012 - 2026)
Ptc Therapeutics' (PTCT) quarterly Net Margin came in at 1.03% in Q1 2026, down 7471.0% year-on-year from 0.01% in Q1 2025, and up 98.65% quarter-over-quarter from 76.14% in Q4 2025.
Ptc Therapeutics (PTCT) Net Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' Net Margin history runs 15 years deep, the most recent figure standing at 1.03% for Q1 2026.
- On a quarterly basis, Net Margin fell 7471.0% year-over-year to 1.03% in Q1 2026; TTM through Mar 2026 was 21.42%, a 5892.0% decrease from a year earlier, with the FY2025 full-year figure at 36.68%, up 8171.0% from the prior year.
- Net Margin rose to 1.03% in Q1 2026 per PTCT's latest filing, from 76.14% in the prior quarter.
- Across five years, Net Margin topped out at 73.68% in Q1 2025 and bottomed at 102.08% in Q4 2022.
- The 5-year median for Net Margin is 52.47% (2023), against an average of 47.8%.
- Across the five-year window, Net Margin jumped 11726 bps in 2025 and plunged 7471 bps in 2026, its largest moves.
- Year by year, Net Margin stood at 102.08% in 2022, then soared by 50 bps to 50.74% in 2023, then soared by 39 bps to 30.91% in 2024, then slumped by 146 bps to 76.14% in 2025, then surged by 99 bps to 1.03% in 2026.
- Per Business Quant, the three latest PTCT Net Margin figures stand at 1.03% (Q1 2026), 76.14% (Q4 2025), and 7.53% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn | -1.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03% |
| Dec 31, 2025 | -76.14% |
| Sep 30, 2025 | 7.53% |
| Jun 30, 2025 | -36.25% |
| Mar 31, 2025 | 73.68% |
| Dec 31, 2024 | -30.91% |
| Sep 30, 2024 | -54.20% |
| Mar 31, 2024 | -43.58% |
| Dec 31, 2023 | -50.74% |
| Sep 30, 2023 | -67.64% |
| Jun 30, 2023 | -93.02% |
| Mar 31, 2023 | -63.05% |
| Dec 31, 2022 | -102.08% |
| Sep 30, 2022 | -50.35% |
| Jun 30, 2022 | -91.88% |
| Mar 31, 2022 | -85.20% |
| Dec 31, 2021 | -86.71% |
| Sep 30, 2021 | -96.31% |
| Jun 30, 2021 | -101.45% |
| Mar 31, 2021 | -109.07% |